Allarity Therapeutics, Inc. Repayments of Related Party Debt
Allarity Therapeutics, Inc. (ALLR) reported Repayments of Related Party Debt of $3.70 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfRelatedPartyDebt · last filed 2023-11-14
- Allarity Therapeutics, Inc. repayments of related party debt for the quarter ending 2021-12-31 was $11.00K.
- Allarity Therapeutics, Inc. repayments of related party debt for the quarter ending 2020-12-31 was -$3.00K.
- Allarity Therapeutics, Inc. repayments of related party debt for fiscal 2021 was $2.94M, a 452.53% increase from fiscal 2020.
- Allarity Therapeutics, Inc. repayments of related party debt for fiscal 2020 was $533.00K.
| Period end | Repayments of Related Party Debt 3 month | Repayments of Related Party Debt 9 month | Repayments of Related Party Debt 12 month | Repayments of Related Party Debt 12 month as first filed |
|---|---|---|---|---|
| 2023-09-30 | $3.70M 10-Q · filed 2023-11-14 | |||
| 2021-12-31 | $11.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2023-03-13 | $2.94M 10-K · filed 2023-03-13 | $2.94M 10-K · filed 2022-05-17 | |
| 2021-09-30 | $2.93M 10-Q/A · filed 2022-05-17 | |||
| 2020-12-31 | -$3.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2022-05-17 | $533.00K 10-K · filed 2022-05-17 | ||
| 2020-09-30 | $536.00K 10-Q/A · filed 2022-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |